Gyre Therapeutics (GYRE) Receivables - Other (2012 - 2026)
Gyre Therapeutics (GYRE) reported Receivables - Other of $200000.0 for Q1 2026, little changed year-over-year from $200000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.
Gyre Therapeutics (GYRE) has 7 years of Receivables - Other data on file, last reported at $200000.0 in Q1 2026.
- Quarterly Receivables - Other changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $200000.0, changed 0.0% from the prior year.
- Receivables - Other was little changed at $200000.0 in Q1 2026 per GYRE's latest filing, from $200000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1.2 million in Q3 2023 and bottomed at $200000.0 in Q4 2024.
- The 4-year median for Receivables - Other is $300000.0 (2023), against an average of $490909.1.
- Peak annual rise in Receivables - Other reached 166.67% in 2024, while the deepest fall reached 75.0% in 2024.
- Tracing GYRE's Receivables - Other over 4 years: stood at $800000.0 in 2023, then tumbled by 75.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Per Business Quant, the three latest GYRE Receivables - Other figures stand at $200000.0 (Q1 2026), $200000.0 (Q4 2025), and $200000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Dec 31, 2014 | 13,000.00 |
| Dec 31, 2014 | 13,000.00 |
| Dec 31, 2013 | 183,000.00 |
| Dec 31, 2013 | 183,000.00 |
| Sep 30, 2013 | 32,000.00 |
| Sep 30, 2013 | 32,000.00 |
| Dec 31, 2012 | 1.05 Mn |
| Dec 31, 2012 | 1.05 Mn |